Morgan Stanley analyst James Faucette lowered the firm’s price target on Chime (CHYM) to $30 from $40 and keeps an Overweight rating on the shares. The firm, which says it liked product updates across MyPay, Instant Loans, ChimeCard and premium tiers that are supporting ARPU expansion and upmarket customer momentum, lowers its price target on a broader peer derating.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHYM: